Freedom Meditech, a developer of non-invasive, ophthalmic-based products to detect and manage diabetes, has released clinical study results of non-invasive glucose monitoring system I-SugarX at the Diabetes Technology Meeting in Bethesda, Maryland.
The I-SugarX is a handheld, ocular glucose measurement device that is intended to provide people with diabetes a convenient, pain-free, and bloodless way to monitor daily glycemic control.
Freedom Meditech’s study results showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.
The study showed that the I-SugarX non-invasive polarimetric based measurements of glucose in the aqueous humor of eye tracked glucose measurements in the blood with 93% of readings in the A zone and the remaining seven percent in the B zone of the Clarke Error Grid (CEG).
The reference glucose sensors used in the study were the Johnson and Johnson LifeScan One Touch Ultra glucose meter and the Yellow Springs Instrument glucose analyzer.
Freedom Meditech chief science officer John Burd said that the eye can be thought of as an optical window into to body for the painless measurement of glucose in the ocular fluid as opposed to the blood, and is well suited for our proprietary optical polarimetric based measurements.
“Based on the results of this, and other studies, we plan to begin human clinical studies as we continue our product development,” Burd said.